Vivo Capital, LLC Apellis Pharmaceuticals, Inc. Transaction History

Vivo Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$24.09 - $32.18 $9.24 Million - $12.3 Million	-383,538 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$12.81 - $19.82 $6.29 Million - $9.73 Million	-491,035 Reduced 56.15%	383,538 $7.48 Million
Q4 2018 Feb 13, 2019	SELL	$11.47 - $18.71 $5.51 Million - $8.98 Million	-479,981 Reduced 35.43%	874,573 $11.5 Million
Q3 2018 Nov 13, 2018	SELL	$16.57 - $21.03 $1.69 Million - $2.14 Million	-101,945 Reduced 7.0%	1,354,554 $24.1 Million
Q2 2018 Aug 10, 2018	SELL	$19.63 - $30.0 $26,206 - $40,050	-1,335 Reduced 0.09%	1,456,499 $32 Million
Q4 2017 Feb 09, 2018	BUY	$12.71 - $21.7 $18.5 Million - $31.6 Million	1,457,834	1,457,834 $31.6 Million

309

115M

3.85M

1.09M

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $3.79B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

Get notified when there are updates to the investment portfolio of Vivo Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Vivo Capital, LLC with notifications on news.